CONTRA: Hydroxyethyl starch solutions are unsafe in critically ill patients (Q37521934)

20 August 2017

1 reference

title

CONTRA: Hydroxyethyl starch solutions are unsafe in critically ill patients (English)

1 reference

20 August 2017

Christiane Hartog

1

1 reference

20 August 2017

Konrad Reinhart

series ordinal

2

1 reference

20 August 2017

publication date

17 June 2009

1 reference

20 August 2017

published in

Intensive Care Medicine

1 reference

20 August 2017

volume

35

1 reference

20 August 2017

issue

8

1 reference

20 August 2017

page(s)

1337-1342

1 reference

Foamy macrophage syndrome due to hydroxyethyl starch replacement: a severe side effect in plasmapheresis

20 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00134-009-1521-5

RETRACTED: Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of a new starch preparation with gelatin.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00134-009-1521-5

[Accumulation of two different hydroxyethyl starch preparations in the placenta after hemodilution in patients with fetal intrauterine growth retardation or pregnancy hypertension]

21 January 2018

1 reference

12 December 2020

Hydrops lysosomalis generalisatus--an underestimated side effect of hydroxyethyl starch therapy?

1 reference

12 December 2020

Effect of fluid loading with saline or colloids on pulmonary permeability, oedema and lung injury score after cardiac and major vascular surgery

1 reference

12 December 2020

Hemodilution therapy with hydroxyethyl starch solution (130/0.4) in unilateral idiopathic sudden sensorineural hearing loss: a dose-finding, double-blind, placebo-controlled, international multicenter trial with 210 patients.

1 reference

12 December 2020

Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses

1 reference

12 December 2020

Comparison of three fluid solutions for resuscitation in dengue shock syndrome

1 reference

12 December 2020

Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation

1 reference

12 December 2020

Colloids versus crystalloids for fluid resuscitation in critically ill patients

1 reference

12 December 2020

Pruritus precipitated by hydroxyethyl starch: a review

1 reference

12 December 2020

Tissue Storage of 14 C-Labelled Hydroxyethyl Starch (HES) 130/0.4 and HES 200/0.5 after Repeated Intravenous Administration to Rats

1 reference

12 December 2020

A systematic review of the comparative safety of colloids

1 reference

12 December 2020

RETRACTED: Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery

1 reference

12 December 2020

RETRACTED: Volume replacement with HES 130/0.4 may reduce the inflammatory response in patients undergoing major abdominal surgery

1 reference

12 December 2020

Intensive insulin therapy and pentastarch resuscitation in severe sepsis

1 reference

12 December 2020

Differential storage of hydroxyethyl starch (HES) in the skin: an immunoelectron-microscopical long-term study.

1 reference

12 December 2020

A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset pre-eclampsia

1 reference

12 December 2020

Hydroxyethyl starch (HES) [130/0.4], a new HES specification: pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers

1 reference

12 December 2020

Renal effects of hypotensive anaesthesia in combination with acute normovolaemic haemodilution with hydroxyethyl starch 130/0.4 or isotonic saline

1 reference

12 December 2020

The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment

1 reference

12 December 2020

Effect of brain-dead donor resuscitation on delayed graft function: results of a monocentric analysis

1 reference

12 December 2020

Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study.

1 reference

12 December 2020

Roundtable debate: Controversies in the management of the septic patient--desperately seeking consensus

1 reference

12 December 2020

Improved outcomes during cardiac surgery: a multifactorial enhancement of cardiopulmonary bypass techniques

1 reference

12 December 2020

Hypervolemic hemodilution in acute ischemic stroke: the Multicenter Austrian Hemodilution Stroke Trial (MAHST)

1 reference

12 December 2020

Acquired lysosomal storage caused by frequent plasmapheresis procedures with hydroxyethyl starch

1 reference

12 December 2020

Volume expansion with albumin decreases mortality after coronary artery bypass graft surgery.

1 reference

12 December 2020

Repetitive Large-Dose Infusion of the Novel Hydroxyethyl Starch 130/0.4 in Patients with Severe Head Injury

1 reference

12 December 2020

Hydroxyethyl starch for hypervolemic hemodilution in patients with acute ischemic stroke: a randomized, placebo-controlled phase II safety study

1 reference

12 December 2020

Hetastarch and bleeding complications after coronary artery surgery

1 reference

12 December 2020

Volume replacement strategies on intensive care units: results from a postal survey

1 reference

12 December 2020

RETRACTED: The value of an albumin-based intravascular volume replacement strategy in elderly patients undergoing major abdominal surgery

1 reference

12 December 2020

A comparison of albumin and saline for fluid resuscitation in the intensive care unit

1 reference

12 December 2020

The effects of hydroxyethyl starch solution in critically ill patients

1 reference

12 December 2020

RETRACTED: Influence of different volume replacement strategies on inflammation and endothelial activation in the elderly undergoing major abdominal surgery

1 reference

12 December 2020

The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials

1 reference

12 December 2020

Effects of hydroxyethyl starch administration on renal function in critically ill patients † ‡

1 reference

12 December 2020

RETRACTED: Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin

1 reference

12 December 2020

Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation

1 reference

12 December 2020

Effects of fluid therapy following aneurysmal subarachnoid haemorrhage: a prospective clinical study

1 reference

12 December 2020

Acquired type I von Willebrand's disease associated with highly substituted hydroxyethyl starch

1 reference

12 December 2020

Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding

1 reference

12 December 2020

Distribution of normal saline and 5% albumin infusions in septic patients

1 reference

12 December 2020

Renal histopathological lesions after orthotopic liver transplantation (OLT).

1 reference

12 December 2020

Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusions.

1 reference

12 December 2020

Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients

1 reference

12 December 2020

10.1007/S00134-009-1521-5

Identifiers

DOI

1 reference

20 August 2017

1 reference